Flow Cytometry for the Diagnosis of Primary Immunodeficiency Diseases: A Single Center Experience.

CONCLUSIONS: The initial application of FCM, particularly with known protein targets on immune cells, would facilitate the timely diagnosis of PIDs and thus would support clinical decisions and improve the clinical outcome. PMID: 32009323 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/32009323?dopt=Abstract

Source: Allergy, Asthma and Immunology Research - February 7, 2020 Category: Allergy & Immunology Tags: Allergy Asthma Immunol Res Source Type: research